Your Advocates Ltd’s Gilead Sciences GILD Stock Holding History

Your Advocates Ltd’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-300	Closed	-$25.2K	–	219
2024 Q3	$25.2K	Hold	300	–	–	0.01%	81
2024 Q2	$20.6K	Hold	300	–	–	0.01%	88
2024 Q1	$22K	Hold	300	–	–	0.01%	85
2023 Q4	$24.3K	Hold	300	–	–	0.01%	80
2023 Q3	$22.5K	Hold	300	–	–	0.01%	76
2023 Q2	$23.1K	Hold	300	–	–	0.01%	83
2023 Q1	$24.9K	Hold	300	–	–	0.01%	64
2022 Q4	$25.8K	Hold	300	–	–	0.01%	66
2022 Q3	$19K	Hold	300	–	–	0.01%	65
2022 Q2	$19K	Hold	300	–	–	0.01%	70
2022 Q1	$18K	Hold	300	–	–	0.01%	80
2021 Q4	$22K	Hold	300	–	–	0.01%	62
2021 Q3	$21K	Hold	300	–	–	0.01%	64
2021 Q2	$21K	Hold	300	–	–	0.01%	61
2021 Q1	$19K	Hold	300	–	–	0.01%	60
2020 Q4	$17K	Hold	300	–	–	0.01%	66
2020 Q3	$19K	Hold	300	–	–	0.01%	58
2020 Q2	$23K	Hold	300	–	–	0.02%	56
2020 Q1	$22K	Buy	+300	New	+$20.7K	0.02%	48

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Your Advocates Ltd's GILD Position: Q4 2024 in Review

Your Advocates Ltd sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 300 shares — an estimated $25.2K sold.

Your Advocates Ltd first reported a position in GILD in Q1 2020 and held it in 19 quarters. The position peaked at $25.8K in Q4 2022. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

Your Advocates Ltd reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
Your Advocates Ltd sold 300 Gilead Sciences shares in Q4 2024, an estimated $25.2K.
Your Advocates Ltd first reported a position in Gilead Sciences in Q1 2020 and held it in 19 quarters.
Your Advocates Ltd's Gilead Sciences position peaked at $25.8K in Q4 2022.
1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Your Advocates Ltd's 13F filing for Q4 2024, filed 4 Feb 2025.